Catalyst Pharmaceuticals stock shines with FIRDAPSE & AGAMREE growth. Learn why the biopharma name is cheap enough to start ...

Stellenbosch head coach Steve Barker has called on his team to bounce back immediately when they face Magesi at the Seshego ...

Cardinal's pharmaceutical and specialty solutions segment distributes branded, generic, and specialty drugs and over-the-counter healthcare and consumer products. Cardinal plays a central role in the ...

The Sweet Amber scent is Humble’s first aromatherapy product, partly inspired by the brand’s origins in Taos, New Mexico (known as a destination for healing). The amber used in the cruelty-free, ...

Ask what is transforming the insurance landscape in Asia today, and the answer comes without recourse to futurist ...

The Sweet Amber scent is Humble’s first aromatherapy product, partly inspired by the brand’s origins in Taos, New Mexico (known as a destination for healing). The amber used in the cruelty-free, ...

These products are used in the company’s specialized end products or sold externally. Celanese produces these commodity chemicals in its acetyl chain segment, which generates about half of companywide ...

Q3 2025 Earnings Call Transcript August 8, 2025 Embecta Corp. beats earnings expectations. Reported EPS is $1.12, ...

Nebius Group ($NBIS) has been a breakout star of 2025 within niche AI, soaring 170% year-to-date. Last week’s Q2 2025 results ...

YUPELRI® (revefenacin) net sales of $66.3 million, recognized by Viatris, increased 22% year-over-year1 Pivotal Phase 3 CYPRESS study enrollment on track to complete ...

Agenus shareholders have suffered a modest ~13% loss since my last analysis, based on cash flow challenges and lack of near ...

YUTREPIA surpasses 900 unique patient prescriptions and 550 patient starts within 11 weeks after approval to treat PAH and PH-ILDPositive interim data from ASCENT trial reinforces YUTREPIA's tolerabil ...